New Key Statistics Module, Z-Score and F-Score
NAS:KZR Key Ratios
| Market Cap $ M | 56.25 |
| Enterprise Value $ M | -122.58 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.32 |
| Price/Sales | 8.56 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 7.00 |
| EPS (TTM) $ | -1.41 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 11.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 1.22 |
| EV-to-EBITDA | 1.24 |
| PEG | -- |
| Shares Outstanding M | 72.80 |
| Net Margin (%) | -1,455.29 |
| Operating Margin % | -1,503.39 |
| Pre-tax Margin (%) | -1,455.29 |
| Quick Ratio | 11.66 |
| Current Ratio | 11.66 |
| ROA % (ttm) | -38.65 |
| ROE % (ttm) | -43.98 |
| ROIC % (ttm) | -465.72 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.59 |
KZR Number of Guru Trades
KZR Volume of Guru Trades
Gurus Latest Trades with NAS:KZR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:KZR is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Kezar Life Sciences Inc Insider Transactions
No Available Data
News about NAS:KZR
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers